China Biological Sample Handling market is expected to grow at CAGR of around 9.7% during the forecast period. China’s market has both medium and long-term potential in the biological sample handling market in the life science industry. This is majorly due to its large pharmaceutical market size, presence of a number of biobanks, and fluctuating disease profile, Furthermore, the Chinese economy is becoming an R&D concentrated economy coupled with the presence of a wide range of CROs. A biobanking infrastructure plays a significant role in the collection, storage, and usage of human biological samples.
Chinese biobank development has made great progress in recent years. This is certainly due to the increasing recognition of the importance of investing in biobanking and research infrastructure, in particular, owing to which, the Government of China is significantly providing funding for biobanking. The most recent and largest development in biobanks is the establishment of Shenzhen-based China National GeneBank (CNGB), a commercial genomics company. Through the development of biobanks in the country, China is focusing on laying a foundation to promote the R&D of translational medicine, personalized medicine, and life science industry, in order to improve the treatment of most prevailing diseases in the country.
Stem cell therapy is a promising method for treating patients with a wide range of diseases and injuries. Increasing government funding for scientific research has promoted rapid developments in stem-cell research in China. According to National Institutes of Health, China has been able to establish around 100 stem cell banks; 10 stem cell drugs are currently in the approval process, and more than 400 stem cell-based clinical trials were registered in the country in 2017. This, in turn, is anticipated to propel the demand for biological sample handling in these clinical trials in China in the near future. China has increased its investments in the biomedical research, invested heavily in stem cell research medicine in recent years.
Research Methodology
The market study of the China Biological Sample Handling market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for biological sample handling companies, storage companies, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. China Biological Sample Handling Market by Storage Type
5.1.1. Cold Storage
5.1.2. Room Temperature Storage
5.2. China Biological Sample Handlings Market by Application
5.2.1. Drug Discovery
5.2.2. Forensic Investigation
5.2.3. DNA Extraction
5.2.4. Proteomics and Genomics Studies
5.2.5. Others
5.3. China Biological Sample Handlings Market by Ownership
5.3.1. Commercial
5.3.2. Academic/Research
6. Company Profiles
6.1. Abbott Laboratories
6.2. Becton, Dickinson And Co.
6.3. Brooks Automation, Inc.
6.4. Fisher BioServices
6.5. Sigma-Aldrich Co. LLC.
6.6. Technidata
1. CHINA BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY STORAGE TYPE, 2018-2025 ($ MILLION)
2. CHINA BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
3. CHINA BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY OWNERSHIP, 2018-2025 ($ MILLION)
1. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY STORAGE TYPE, 2018 VS 2025 (%)
2. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY OWNERSHIP, 2018 VS 2025 (%)